QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer

NCT04864782 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Phase 2 completed, phase 3 sponsor decided to terminate

Conditions

Cervical Cancer

Interventions

DRUG: QL1604
DRUG: Paclitaxel injection
DRUG: Cisplatin/Carboplatin

Sponsor

Qilu Pharmaceutical Co., Ltd.